{
  "report_rows": [
    {
      "kpi": "Operating diluted EPS",
      "prediction": "IN-LINE",
      "answer": "pred ~$2.26 vs. cons $2.244",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Net sales",
      "prediction": "IN-LINE",
      "answer": "pred ~$4.37B vs. cons $4.356B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Organic sales growth",
      "prediction": "BEAT",
      "answer": "pred ~2.1% vs. cons 1.98%",
      "confidence": "LOW"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY2026 adjusted EPS ($7.70\u2013$8.10 official range)",
      "prediction": "UNCHANGED",
      "answer": "guide midpoint ~$7.90 vs. cons $7.869",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q3 EPS / H2 margin commentary",
      "prediction": "UNCHANGED",
      "answer": "guide ~H2 improvement vs. cons Q3 EPS $2.118",
      "confidence": "LOW"
    }
  ],
  "day1_residual_pct": -3.0,
  "day1_confidence": "LOW",
  "day5_residual_pct": -4.5,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "FOLLOW-THROUGH \u2014 maintained FY guidance likely leaves forward estimates static after a rich stock run",
  "day5_confidence": "LOW"
}